ArticleJournal of clinical neurology (Seoul, Korea)2018

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis.

Martina Garnero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.